Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/279764 
Year of Publication: 
2023
Series/Report no.: 
ECONtribute Policy Brief No. 055
Publisher: 
University of Bonn and University of Cologne, Reinhard Selten Institute (RSI), Bonn and Cologne
Abstract: 
The European Commission is considering new ways to regulate the 'substances of human origin' - including blood, plasma, and cells - used in medical procedures from transfusions and transplants to assisted reproduction. This column argues that such legislation jeopardises the interests of both donors and recipients. While sympathetic to the intentions behind the proposals - which aim to ensure that donations are voluntary and to protect financially disadvantaged donors - the authors believe such rules overlook the effects on donors, on the supply of such substances, and on the health of those who need them.
Document Type: 
Research Report

Files in This Item:
File
Size
391.68 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.